Virtual Medicinal Product (VMP) - Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Conjugated oestrogens 625microgram / Medroxyprogesterone 5mg tablets Start Date 25-06-2010 End Date
Previous Name Previous Name Medroxyprogesterone 5mg / Conjugated oestrogens 625microgram tablets Start Date 20-04-2004 End Date 24-06-2010
Abbreviated Name Abbreviated Name Conjugated oestrogens 625microg/Medroxyprogesterone 5mg tab Start Date 25-06-2010
Previous Abbreviated Name Medroxyprogesterone 5mg/Conjugated oestrogens 625microg tab Previous Start Date 01-05-2009 Previous End Date 24-06-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
G03FA12
BNF Start Date End Date
Current BNF 06040101 Start Date 04-04-2022 End Date
Previous BNF 06040101 Start Date 15-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39689411000001101 26-05-2021
409322009 22-08-2005 25-05-2021
3514511000001106 26-11-2002 21-08-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Conjugated oestrogens Based on Ingredient Substance 625 microgram
Medroxyprogesterone acetate Based on Ingredient Substance 5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
84 tablet